RAPAFLO
- Product NDC
- 52544-151
- 11-digit product format
- 525440151
- Labeler code
- 52544
- Product ID
- 52544-151_01d2cfa3-9fd9-44ef-91db-71e5800d838d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- silodosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- NDA022206
- Marketing category
- NDA
- Marketing start
- 2009-03-23
- Marketing end
- 2020-10-31
- Substance
- SILODOSIN
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record